clofibric acid has been researched along with Myocardial Infarction in 10 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The immunomodulatory effect of the lipid-reducing etofibrate, the calcium antagonist nifedipine and the immunosuppressive cyclosporine A was studied on in vitro cellular immune response in the presence of human aortic extract and of human LDL in 56 patients with acute myocardial infarction." | 3.68 | The effect of some drugs on in vitro cellular immune reactions and on circulating immune complexes in patients with myocardial infarction. ( Geró, S; Horváth, M; Jósfay, A; Mezey, Z; Nánay, I; Varsányi, M, 1991) |
| "Niacin was started after recurrence." | 1.36 | Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report. ( Lupattelli, G; Mannarino, E; Roscini, AR; Siepi, D, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jakob, T | 1 |
| Nordmann, AJ | 1 |
| Schandelmaier, S | 1 |
| Ferreira-González, I | 1 |
| Briel, M | 1 |
| Lupattelli, G | 1 |
| Roscini, AR | 1 |
| Siepi, D | 1 |
| Mannarino, E | 1 |
| Robins, SJ | 1 |
| Schwiesow, SJ | 1 |
| Nappi, JM | 1 |
| Ragucci, KR | 1 |
| Klose, G | 1 |
| Barter, PJ | 1 |
| Rye, KA | 1 |
| Kohro, T | 1 |
| Hayashi, D | 1 |
| Okada, Y | 1 |
| Yamazaki, T | 1 |
| Nagai, R | 1 |
| Chandler, HA | 1 |
| Batchelor, AJ | 1 |
| Athyros, VG | 1 |
| Papageorgiou, AA | 1 |
| Kontopoulos, AG | 1 |
| Horváth, M | 1 |
| Mezey, Z | 1 |
| Jósfay, A | 1 |
| Nánay, I | 1 |
| Varsányi, M | 1 |
| Geró, S | 1 |
3 reviews available for clofibric acid and Myocardial Infarction
| Article | Year |
|---|---|
Fibrates for primary prevention of cardiovascular disease events.
Topics: Atorvastatin; Bezafibrate; Cardiovascular Diseases; Clofibric Acid; Fenofibrate; Gemfibrozil; Humans | 2016 |
Cardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy?
Topics: Anticholesteremic Agents; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; | 2003 |
Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome?
Topics: Cardiovascular Diseases; Cholesterol, HDL; Clofibric Acid; Humans; Hypertriglyceridemia; Hypolipidem | 2008 |
1 trial available for clofibric acid and Myocardial Infarction
| Article | Year |
|---|---|
Statin-fibrate combinations in patients with combined hyperlipedemia.
Topics: Clofibric Acid; Coronary Disease; Drug Therapy, Combination; Fibric Acids; Follow-Up Studies; Gemfib | 2001 |
6 other studies available for clofibric acid and Myocardial Infarction
| Article | Year |
|---|---|
Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report.
Topics: Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Fluorobenzenes; Humans; Hydroxymethylglutaryl-Co | 2010 |
Assessment of compliance with lipid guidelines in an academic medical center.
Topics: Academic Medical Centers; American Heart Association; Angioplasty, Balloon, Coronary; Cerebrovascula | 2006 |
[New studies of high dosage statins and fibrates. How is lipid lowering therapy changing? (interview by Dr. med. Dirk Einecke)].
Topics: Anticholesteremic Agents; Cholesterol, LDL; Clofibric Acid; Coronary Artery Disease; Dose-Response R | 2005 |
Effects of medication on cardiovascular events in the Japanese coronary artery disease (JCAD) study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Calcium Cha | 2007 |
Ciprofibrate and lipid profile.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Fibric Acids; Humans; Hyperlipidemi | 1994 |
The effect of some drugs on in vitro cellular immune reactions and on circulating immune complexes in patients with myocardial infarction.
Topics: Aged; Antigen-Antibody Complex; Aorta; Cell Migration Inhibition; Clofibric Acid; Cyclosporine; Fema | 1991 |